Bain Linda 4

What Happened

• Linda Bain, a director of Autolus Therapeutics plc (AUTL), was granted two restricted stock unit (RSU) awards on June 29, 2026 totaling 79,167 RSUs (31,667 + 47,500). Each RSU was granted at $0.00 and is a derivative award that represents a contingent right to receive one American Depositary Share (ADS), which is convertible into one ordinary share upon settlement. The grants have a vesting date of June 29, 2027.

Key Details

• Transaction date: 2026-06-29; Form 4 filed: 2026-07-01 (appears timely—filed two days after the grant).
• Price: $0.00 per RSU; total reported acquisition value: $0 (derivative awards).
• Total RSUs granted: 79,167 (31,667 + 47,500).
• Vesting: RSUs vest in one installment on June 29, 2027 (Footnote F2).
• RSU mechanics: Each RSU = right to one ADS; each ADS is convertible into one ordinary share (Footnote F1).
• Shares owned after transaction: Not reported in this filing.
• Other plan details: The filing notes existing share options (vesting monthly starting July 29, 2026) for the reporting person (Footnote F3).
• No sale, purchase, tax-withholding disposition, or 10b5-1 plan indicated in this Form 4.

Context

• This filing documents a grant of equity-based compensation (an award), not an open-market purchase or sale. Grants to directors are common as part of compensation and do not by themselves indicate a personal purchase or sale decision.
• Because these are RSUs (derivative awards), shares will only be issued if and when the RSUs vest and any applicable conditions are satisfied.